On October 17, 2023, Virax Biolabs Group Limited closed the transaction. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.83 USD | -1.13% | +4.63% | -43.15% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.15% | 1.96M | |
+41.79% | 54.04B | |
+47.13% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited announced that it has received $2.15 million in funding